RNS Number : 3696V Renalytix AI PLC 14 April 2021       Renalytix AI plc   (" RenalytixAI " or the " Company ")     RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platform   Agreement provides RenalytixAI with exclusive option to access

RNS Number : 7571U Renalytix AI PLC 08 April 2021       Renalytix AI plc   (" RenalytixAI " or the " Company ")     Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions   Value of KidneyIntelX Testing Demonstrated by Data from 401

RNS Number : 4091U Renalytix AI PLC 06 April 2021       Renalytix AI plc   (" RenalytixAI " or the " Company ")     Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure  

RNS Number : 1874S Renalytix AI PLC 15 March 2021   Renalytix AI plc (" RenalytixAI " or the " Company ")   Update on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics   NEW YORK , March 15, 2021 - Renalytix AI plc   (LSE : RENX) (NASDAQ:

RNS Number : 2460R Renalytix AI PLC 04 March 2021     Renalytix AI plc ("RenalytixAI", the "Company" or the "Group")   Issue of shares under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting Rights   New York , 4 March 2021 - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX),, an

RNS Number : 8363Q Renalytix AI PLC 02 March 2021   RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021   NEW YORK , March 2, 2021   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX) ("RenalytixAI" or the "Company"), an artificial intelligence-enabled in vitro diagnostics

RNS Number : 8349Q Renalytix AI PLC 02 March 2021     Renalytix AI plc ("RenalytixAI", the "Company" or the "Group")   Half-year Report   Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), ("RenalytixAI" or the "Company"), an artificial intelligence-enabled in vitro diagnostics company, focused on

RNS Number : 1616Q Renalytix AI PLC 24 February 2021   This announcement contains inside information   Renalytix AI plc (" RenalytixAI " or the " Company ")   The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health   Innovative partnership to enable health system-wide

RNS Number : 9649P Renalytix AI PLC 23 February 2021     Renalytix AI plc (" RenalytixAI " or the " Company ")   RenalytixAI to announce Financial Results for six and three months ended December 31, 2020   NEW YORK , February 23, 2021   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX), the

RNS Number : 9849N Renalytix AI PLC 04 February 2021     Renalytix AI plc (" RenalytixAI " or the " Company ")   American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health     Event Featuring Leading Clinicians, Biotech Innovators and Federal Health